Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 959
Gene Symbol: CD40LG
CD40LG
0.020 Biomarker disease LHGDN Immunohistochemistry was used to examine expression of BCL2, BAX, P53, CD40 and CD40L in archival tissues of patients included in various treatment trials for transitional cell carcinoma (TCC) of the bladder. 12592374 2003
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.020 GeneticVariation disease LHGDN Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. 14633685 2003
Entrez Id: 8140
Gene Symbol: SLC7A5
SLC7A5
0.010 AlteredExpression disease LHGDN In conclusion, the detection of the active form of LAT1 protein would appear to be of value in informing the risk of progression in transitional cell carcinoma of the upper urinary tract. 17622555 2007
Entrez Id: 29767
Gene Symbol: TMOD2
TMOD2
0.010 AlteredExpression disease LHGDN Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. 15095301 2004
Entrez Id: 4316
Gene Symbol: MMP7
MMP7
0.010 AlteredExpression disease LHGDN However, the expression of MMP-7 in transitional cell carcinoma (TCC) of the urinary bladder has not been previously investigated. 12579270 2003
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.010 Biomarker disease LHGDN A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. 19115207 2009
Entrez Id: 4103
Gene Symbol: MAGEA4
MAGEA4
0.010 AlteredExpression disease LHGDN Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. 12209610 2002
Entrez Id: 3135
Gene Symbol: HLA-G
HLA-G
0.010 GeneticVariation disease LHGDN HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. 18721275 2008
Entrez Id: 356
Gene Symbol: FASLG
FASLG
0.010 AlteredExpression disease LHGDN Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression. 12651606 2003
Entrez Id: 302
Gene Symbol: ANXA2
ANXA2
0.010 Biomarker disease LHGDN These findings suggest that annexin 2 mediated fibrinolysis on the transitional cell carcinoma cells may play a role in inducing hemorrhagic disorder in vascular intimal carcinomatosis. 16524621 2007
Entrez Id: 2167
Gene Symbol: FABP4
FABP4
0.010 Biomarker disease LHGDN A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. 19115207 2009
Entrez Id: 916
Gene Symbol: CD3E
CD3E
0.010 AlteredExpression disease LHGDN Expression of CD3 antigens in renal tubule epithelium and renal oncocytomas. 16308105 2005
Entrez Id: 598
Gene Symbol: BCL2L1
BCL2L1
0.010 Biomarker disease LHGDN Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma. 19020723 2008
Entrez Id: 29766
Gene Symbol: TMOD3
TMOD3
0.010 AlteredExpression disease LHGDN Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. 15095301 2004
Entrez Id: 3732
Gene Symbol: CD82
CD82
0.010 AlteredExpression disease LHGDN Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder. 17393117 2007
Entrez Id: 5329
Gene Symbol: PLAUR
PLAUR
0.010 AlteredExpression disease LHGDN We investigated uPA and uPAR gene expression in 20 human transitional cell carcinomas (TCC) of the bladder (n=19) and the renal pelvis (n=1) in comparison with adjacent non-malignant tissues. 15375521 2004
Entrez Id: 6469
Gene Symbol: SHH
SHH
0.010 Biomarker disease LHGDN Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. 15521068 2005
Entrez Id: 928
Gene Symbol: CD9
CD9
0.010 AlteredExpression disease LHGDN Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder. 17393117 2007
Entrez Id: 7111
Gene Symbol: TMOD1
TMOD1
0.010 AlteredExpression disease LHGDN Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. 15095301 2004
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.530 CausalMutation disease CGI
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.560 Biomarker disease CTD_human Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. 12151359 2002
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.530 Biomarker disease CTD_human Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma. 3433577 1987
Entrez Id: 2261
Gene Symbol: FGFR3
FGFR3
0.400 Biomarker disease CTD_human Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. 24121792 2013
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.400 Biomarker disease CTD_human Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards. 22929185 2012
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.350 Biomarker disease CTD_human Expression of cycloxygenase-2 in human bladder and renal cell carcinoma. 12664575 2002